These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35894539)

  • 1. Cryoprecipitated anti-hemophiliac factor manufactured from plasma frozen within 24 h after phlebotomy meets AABB quality standards.
    Lokhandwala PM; Young PP; White J; Brown BL
    Transfusion; 2022 Sep; 62(9):1731-1735. PubMed ID: 35894539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC.
    Yazer MH; Triulzi DJ; Hassett AC; Kiss JE
    Transfusion; 2010 May; 50(5):1014-8. PubMed ID: 20003046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Coagulation Factors Activity in Different Types of Plasma Preparations.
    Afifi OAH; Abdelsalam EMN; Makhlouf AAEAM; Ibrahim MAM
    Indian J Hematol Blood Transfus; 2019 Jul; 35(3):551-556. PubMed ID: 31388272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention of Coagulation Factors and Storage of Freeze-Dried Plasma.
    Flaumenhaft EJ; Khat T; Marschner S
    Mil Med; 2021 Jan; 186(Suppl 1):400-407. PubMed ID: 33499449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-day stability of thawed plasma: solvent/detergent-treated plasma comparable with fresh-frozen plasma and plasma frozen within 24 hours.
    Neisser-Svae A; Trawnicek L; Heger A; Mehta T; Triulzi D
    Transfusion; 2016 Feb; 56(2):404-9. PubMed ID: 26419404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity of labile coagulation factors and fibrinogen in thawed plasma during a 5 day storage period in the hospital blood bank refrigerator.
    Bahreini S; Javadzadeh Shahshahani H; Nasizadeh S; Ahmadinejad M
    Transfus Med; 2021 Dec; 31(6):494-498. PubMed ID: 34605106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.
    Serrano K; Scammell K; Weiss S; Culibrk B; Levin E; Gyöngyössy-Issa M; Devine DV
    Transfusion; 2010 Feb; 50(2):344-53. PubMed ID: 19843287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6
    Erickson A; Waldhaus K; David T; Huang N; Rico S; Corash L; Mufti N; Benjamin RJ
    Transfusion; 2017 Apr; 57(4):997-1006. PubMed ID: 28150310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation function of never frozen liquid plasma stored for 40 days.
    Meledeo MA; Peltier GC; McIntosh CS; Bynum JA; Corley JB; Cap AP
    Transfusion; 2021 Jul; 61 Suppl 1():S111-S118. PubMed ID: 34269464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the quantity of some stable and labile coagulation factors in fresh-frozen plasma produced from whole blood stored for 24 hours in Iran.
    Naghadeh HT; Roudkenar MH
    Blood Transfus; 2009 Jan; 7(1):39-42. PubMed ID: 19290079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual differences of plasma proteins and factors in fresh frozen plasma from Chinese regional blood donors.
    Zhu L; Li C; Wang D
    J Thromb Thrombolysis; 2019 Apr; 47(3):420-426. PubMed ID: 30637556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing the time-to-freezing for clinical apheresis plasma meets quality specifications.
    Winter KM; Webb RG; Mazur E; Ismay S; Marinakis D; Marks DC
    Vox Sang; 2023 Nov; 118(11):993-996. PubMed ID: 37718663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticle profile and procoagulant activity of fresh-frozen plasma is affected by whole blood leukoreduction rather than 24-hour room temperature hold.
    Chan KS; Sparrow RL
    Transfusion; 2014 Aug; 54(8):1935-44. PubMed ID: 24635475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers.
    Schlenke P; Hervig T; Isola H; Wiesel ML; Kientz D; Pinkoski L; Singh Y; Lin L; Corash L; Cazenave JP
    Transfusion; 2008 Apr; 48(4):697-705. PubMed ID: 18194378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labile coagulation factors in thawed fresh frozen plasma prepared by two methods.
    Kakaiya RM; Morse EE; Panek S
    Vox Sang; 1984; 46(1):44-6. PubMed ID: 6702140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality control of recovered plasma for fractionation: an extensive Italian study.
    Grazzini G; Rossi G; Rafanelli D; Gambelli D; Farina C; Mori F; Zucchelli P; Marchiori G; Breda A; Liumbruno GM
    Transfusion; 2008 Jul; 48(7):1459-68. PubMed ID: 18435675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight.
    Cardigan R; Lawrie AS; Mackie IJ; Williamson LM
    Transfusion; 2005 Aug; 45(8):1342-8. PubMed ID: 16078924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of frozen transfusable plasma prepared from whole blood donations in Canada: an update.
    Sheffield WP; Bhakta V; Talbot K; Pryzdial EL; Jenkins C
    Transfus Apher Sci; 2013 Dec; 49(3):440-6. PubMed ID: 23849252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation factor levels in plasma frozen within 24 hours of phlebotomy over 5 days of storage at 1 to 6 degrees C.
    Yazer MH; Cortese-Hassett A; Triulzi DJ
    Transfusion; 2008 Dec; 48(12):2525-30. PubMed ID: 18774964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.